• 7802 Citations
  • 47 Scopus h-Index
20042020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Letter
2019

A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis

Mascarenhas, J., Kosiorek, H., Prchal, J., Yacoub, A., Berenzon, D., Baer, M. R., Ritchie, E., Silver, R. T., Kessler, C., Winton, E., Finazzi, M. C., Rambaldi, A., Vannucchi, A. M., Leibowitz, D., Rondelli, D., Arcasoy, M. O., Catchatourian, R., Vadakara, J., Rosti, V., Hexner, E. & 12 others, Kremyanskaya, M., Sandy, L., Tripodi, J., Najfeld, V., Farnoud, N., Salama, M. E., Weinberg, R. S., Rampal, R., Goldberg, J. D., Mesa, R., Dueck, A. C. & Hoffman, R., Jan 1 2019, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalLetter

2 Scopus citations

Clinician vs Patient Reporting of Baseline and Postbaseline Symptoms for Adverse Event Assessment in Cancer Clinical Trials

Atkinson, T. M., Dueck, A. C., Satele, D. V., Thanarajasingam, G., Lafky, J. M., Sloan, J. A. & Basch, E., Jan 1 2019, (Accepted/In press) In : JAMA Oncology.

Research output: Contribution to journalLetter

Perceived risk for cancer progression and psychological status in chronic lymphocytic leukemia patients: CALGB 70603 (Alliance)

Deshields, T. L., Dueck, A. C., Rogers, K., Brown, J. R., Shanafelt, T., Mintzer, D. & Byrd, J. C., Aug 24 2019, In : Leukemia and Lymphoma. 60, 10, p. 2580-2583 4 p.

Research output: Contribution to journalLetter

Phase II trial of Lestaurtinib, a JAK2 inhibitor, in patients with myelofibrosis

Mascarenhas, J., Baer, M. R., Kessler, C., Hexner, E., Tremblay, D., Price, L., Sandy, L., Weinberg, R., Pahl, H., Silverman, L. R., Goldberg, J. D., Kosiorek, H., Dueck, A. C. & Hoffman, R., Apr 16 2019, In : Leukemia and Lymphoma. 60, 5, p. 1343-1345 3 p.

Research output: Contribution to journalLetter

4 Scopus citations

Two-Year Survival Comparing Web-Based Symptom Monitoring vs Routine Surveillance Following Treatment for Lung Cancer

Denis, F., Basch, E., Septans, A. L., Bennouna, J., Urban, T., Dueck, A. C. & Letellier, C., Jan 22 2019, In : JAMA - Journal of the American Medical Association. 321, 3, p. 306-307 2 p.

Research output: Contribution to journalLetter

27 Scopus citations
2017

Feasibility study of online yoga for symptom management in patients with myeloproliferative neoplasms

Huberty, J., Eckert, R., Gowin, K., Mitchell, J., Dueck, A., Ginos, B. F., Larkey, L. & Mesa, R., Sep 30 2017, In : Haematologica. 102, 10, p. e384-e388

Research output: Contribution to journalLetter

7 Scopus citations

Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment

Basch, E., Deal, A. M., Dueck, A., Scher, H. I., Kris, M. G., Hudis, C. & Schrag, D., Jul 11 2017, In : JAMA - Journal of the American Medical Association. 318, 2, p. 197-198 2 p.

Research output: Contribution to journalLetter

407 Scopus citations

Patient-reported symptom monitoring during chemotherapy - Reply

Basch, E., Deal, A. M. & Dueck, A., Nov 21 2017, In : JAMA - Journal of the American Medical Association. 318, 19, p. 1935-1936 2 p.

Research output: Contribution to journalLetter

2 Scopus citations
2016

A phase Ib study of the combination of the aurora kinase inhibitor alisertib (MLN8237) and bortezomib in relapsed multiple myeloma

Rosenthal, A., Kumar, S. K., Hofmeister, C., Laubach, J., Vij, R., Dueck, A., Gano, K. & Stewart, A. K., Jul 1 2016, In : British Journal of Haematology. 174, 2, p. 323-325 3 p.

Research output: Contribution to journalLetter

13 Scopus citations

Phase II trial of nab-paclitaxel in patients with relapsed or refractory multiple myeloma

Jain, T., Dueck, A., Kosiorek, H. E., Ginos, B. F., Mayo, A., Reeder, C. B., Chesi, M., Mikhael, J. R., Stewart, A. K., Bergsagel, P. L. & Fonseca, R., Dec 1 2016, In : American Journal of Hematology. 91, 12, p. E504-E505

Research output: Contribution to journalLetter

2 Scopus citations
2012

Response

Perez, E. A. & Dueck, A. C., Jun 20 2012, In : Journal of the National Cancer Institute. 104, 12, p. 958-959 2 p.

Research output: Contribution to journalLetter

2009

Reply to N. Magné et al

Halyard, M. Y., Pisansky, T. M., Dueck, A. C., Suman, V. J., Pierce, L. J., Solin, L. J., Marks, L. B., Davidson, N., Martino, S., Kaufman, P., Kutteh, L., Dakhil, S. & Perez, E. A., Dec 1 2009, In : Journal of Clinical Oncology. 27, 34, p. e240-e241

Research output: Contribution to journalLetter

The authors reply

Caselli, R. J., Dueck, A. C. & Reiman, E. M., Nov 12 2009, In : New England Journal of Medicine. 361, 20, p. 1996-1997 2 p.

Research output: Contribution to journalLetter